[11] [12] This delayed gastric emptying is a key therapeutic effect that helps control postprandial glucose excursions and promotes feelings of fullness
While not a widely recognised side effect of GLP-1 medications, emerging evidence suggests potential links through neuroinflammation, altered pain modulation, and metabolic effects on nerve function
A total of 242 patients with PCOS were included for modeling ( max of carnitine supplementation on body weight was 3.92%, the ET 50 was 3.6 weeks, and the treatment times to achieve 25%, 50%, 75%, and 80% (plateau) E max of carnitine supplementation on body weight were 1.2, 3.6, 10.8, and 14.4 weeks, respectively
These are sophisticated protein-based medications that can literally become unsafe when they go bad